Mathew Maurer, MD
Advanced Heart Failure and Transplant Cardiology · New York, NYNPI 1467527903
Payments from drug & device makers
Across 972 payments — averaging $5172.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$3.2M
- Pfizer$1.2M
- AstraZeneca$202K
- E.r. Squibb & Sons, L.L.C.$166K
- Novo Nordisk AS$86K
- Ionis Pharmaceuticals, Inc.$83K
- plus $129K from 22 others
Across 43 payments — averaging $1561.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$67K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 733 | $3,171,827 |
| Pfizer | 57 | $1,189,155 |
| AstraZeneca(2 entities) | 29 | $201,710 |
| E.r. Squibb & Sons, L.L.C. | 6 | $166,323 |
| Novo Nordisk AS | 23 | $86,242 |
| Ionis Pharmaceuticals, Inc. | 12 | $82,889 |
| Astrazeneca UK Limited | 10 | $50,945 |
| Eidos Therapeutics, Inc. | 6 | $40,071 |
| Abbott | 22 | $11,460 |
| Regeneron | 1 | $5,265 |
| Impulse Dynamics (USA) Inc. | 1 | $4,500 |
| Medtronic(2 entities) | 9 | $4,203 |
| Roche Diagnostics International Ltd | 1 | $3,955 |
| GSK | 3 | $2,925 |
| AbbVie | 1 | $2,100 |
| Bridgebio Pharma, Inc. | 1 | $865 |
| Merck | 3 | $791 |
| Janssen Global Services, LLC | 1 | $620 |
| Novartis | 40 | $582 |
| Cvrx, Inc. | 2 | $308 |
| Abiomed | 1 | $136 |
| Novo Nordisk | 1 | $125 |
| Akcea Therapeutics, Inc. | 1 | $95 |
| Boehringer Ingelheim | 4 | $75 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $29 |
| Amgen | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Novo Nordisk US Research & Development, Inc. | 1 | $8 |
How this compares
$5,027,250 in reported general payments places this provider in the 95th percentile of 106 advanced heart failure and transplant cardiology providers in New York.
See all advanced heart failure and transplant cardiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in New York
- Evelyn HornNew York$2.9M
- Johanna ContrerasNew York$1.4M
- Parag GoyalNew York$1.1M
- Nir UrielNew York$884K
- Tajinderpal SaraonNew York$618K
- Kelly AxsomNew York$502K
- Sean PinneyNew York$414K
- Yevgeniy BrailovskyNew York$339K
- James YoussefNew York$287K
- Alex ReyentovichNew York$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.